Report Detail
Global Lou Gehrigs Disease Market Insights, Forecast to 2025
- RnM2353373 |
- 19 June, 2019 |
- Global |
- 124 Pages |
- QYResearch |
- Pharma & Healthcare
Amyotrophic lateral sclerosis (ALS), also known as motor neurone disease (MND), or Lou Gehrig's disease, is a specific disease which causes the death of neurons controlling voluntary muscles. Some also use the term motor neuron disease for a group of conditions of which ALS is the most common.
The global Lou Gehrigs Disease market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Lou Gehrigs Disease market based on company, product type, end user and key regions.
This report studies the global market size of Lou Gehrigs Disease in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Lou Gehrigs Disease in these regions.
This research report categorizes the global Lou Gehrigs Disease market by top players/brands, region, type and end user. This report also studies the global Lou Gehrigs Disease market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AB Science
Avicena Group
Biogen
BrainStorm Therapeutics
Covis Pharmaceutical Inc.
Cytokinetics Inc.
Eisai Co. Ltd.
GlaxoSmithKline plc.
Ionis Pharmaceuticals, Inc.
Mitsubishi Tanabe Pharma Corp.
Neuralstem Inc.
Neuraltus Pharmaceuticals Inc.
Newron Pharmaceuticals S.p.A.
Nutra Pharma Corp.
Pharnext SAS
Q-Therapeutics Inc.
Market size by Product
Riluzole
Edaravone (Radicava)
Market size by End User
Hospital Pharmacies
Retail & Online Pharmacie
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Lou Gehrigs Disease market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Lou Gehrigs Disease market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Lou Gehrigs Disease companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Lou Gehrigs Disease submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Lou Gehrigs Disease are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Lou Gehrigs Disease market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Lou Gehrigs Disease Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Lou Gehrigs Disease Market Size Growth Rate by Product
- 1.4.2 Riluzole
- 1.4.3 Edaravone (Radicava)
- 1.5 Market by End User
- 1.5.1 Global Lou Gehrigs Disease Market Size Growth Rate by End User
- 1.5.2 Hospital Pharmacies
- 1.5.3 Retail & Online Pharmacie
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Lou Gehrigs Disease Market Size
- 2.1.1 Global Lou Gehrigs Disease Revenue 2014-2025
- 2.1.2 Global Lou Gehrigs Disease Sales 2014-2025
- 2.2 Lou Gehrigs Disease Growth Rate by Regions
- 2.2.1 Global Lou Gehrigs Disease Sales by Regions
- 2.2.2 Global Lou Gehrigs Disease Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Lou Gehrigs Disease Sales by Manufacturers
- 3.1.1 Lou Gehrigs Disease Sales by Manufacturers
- 3.1.2 Lou Gehrigs Disease Sales Market Share by Manufacturers
- 3.1.3 Global Lou Gehrigs Disease Market Concentration Ratio (CR5 and HHI)
- 3.2 Lou Gehrigs Disease Revenue by Manufacturers
- 3.2.1 Lou Gehrigs Disease Revenue by Manufacturers (2014-2019)
- 3.2.2 Lou Gehrigs Disease Revenue Share by Manufacturers (2014-2019)
- 3.3 Lou Gehrigs Disease Price by Manufacturers
- 3.4 Lou Gehrigs Disease Manufacturing Base Distribution, Product Types
- 3.4.1 Lou Gehrigs Disease Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Lou Gehrigs Disease Product Type
- 3.4.3 Date of International Manufacturers Enter into Lou Gehrigs Disease Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Lou Gehrigs Disease Sales by Product
- 4.2 Global Lou Gehrigs Disease Revenue by Product
- 4.3 Lou Gehrigs Disease Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Lou Gehrigs Disease Breakdown Data by End User
6 North America
- 6.1 North America Lou Gehrigs Disease by Countries
- 6.1.1 North America Lou Gehrigs Disease Sales by Countries
- 6.1.2 North America Lou Gehrigs Disease Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Lou Gehrigs Disease by Product
- 6.3 North America Lou Gehrigs Disease by End User
7 Europe
- 7.1 Europe Lou Gehrigs Disease by Countries
- 7.1.1 Europe Lou Gehrigs Disease Sales by Countries
- 7.1.2 Europe Lou Gehrigs Disease Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Lou Gehrigs Disease by Product
- 7.3 Europe Lou Gehrigs Disease by End User
8 Asia Pacific
- 8.1 Asia Pacific Lou Gehrigs Disease by Countries
- 8.1.1 Asia Pacific Lou Gehrigs Disease Sales by Countries
- 8.1.2 Asia Pacific Lou Gehrigs Disease Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Lou Gehrigs Disease by Product
- 8.3 Asia Pacific Lou Gehrigs Disease by End User
9 Central & South America
- 9.1 Central & South America Lou Gehrigs Disease by Countries
- 9.1.1 Central & South America Lou Gehrigs Disease Sales by Countries
- 9.1.2 Central & South America Lou Gehrigs Disease Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Lou Gehrigs Disease by Product
- 9.3 Central & South America Lou Gehrigs Disease by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Lou Gehrigs Disease by Countries
- 10.1.1 Middle East and Africa Lou Gehrigs Disease Sales by Countries
- 10.1.2 Middle East and Africa Lou Gehrigs Disease Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Lou Gehrigs Disease by Product
- 10.3 Middle East and Africa Lou Gehrigs Disease by End User
11 Company Profiles
- 11.1 AB Science
- 11.1.1 AB Science Company Details
- 11.1.2 Company Business Overview
- 11.1.3 AB Science Lou Gehrigs Disease Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 AB Science Lou Gehrigs Disease Products Offered
- 11.1.5 AB Science Recent Development
- 11.2 Avicena Group
- 11.2.1 Avicena Group Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Avicena Group Lou Gehrigs Disease Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Avicena Group Lou Gehrigs Disease Products Offered
- 11.2.5 Avicena Group Recent Development
- 11.3 Biogen
- 11.3.1 Biogen Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Biogen Lou Gehrigs Disease Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Biogen Lou Gehrigs Disease Products Offered
- 11.3.5 Biogen Recent Development
- 11.4 BrainStorm Therapeutics
- 11.4.1 BrainStorm Therapeutics Company Details
- 11.4.2 Company Business Overview
- 11.4.3 BrainStorm Therapeutics Lou Gehrigs Disease Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 BrainStorm Therapeutics Lou Gehrigs Disease Products Offered
- 11.4.5 BrainStorm Therapeutics Recent Development
- 11.5 Covis Pharmaceutical Inc.
- 11.5.1 Covis Pharmaceutical Inc. Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Covis Pharmaceutical Inc. Lou Gehrigs Disease Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Covis Pharmaceutical Inc. Lou Gehrigs Disease Products Offered
- 11.5.5 Covis Pharmaceutical Inc. Recent Development
- 11.6 Cytokinetics Inc.
- 11.6.1 Cytokinetics Inc. Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Cytokinetics Inc. Lou Gehrigs Disease Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Cytokinetics Inc. Lou Gehrigs Disease Products Offered
- 11.6.5 Cytokinetics Inc. Recent Development
- 11.7 Eisai Co. Ltd.
- 11.7.1 Eisai Co. Ltd. Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Eisai Co. Ltd. Lou Gehrigs Disease Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Eisai Co. Ltd. Lou Gehrigs Disease Products Offered
- 11.7.5 Eisai Co. Ltd. Recent Development
- 11.8 GlaxoSmithKline plc.
- 11.8.1 GlaxoSmithKline plc. Company Details
- 11.8.2 Company Business Overview
- 11.8.3 GlaxoSmithKline plc. Lou Gehrigs Disease Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 GlaxoSmithKline plc. Lou Gehrigs Disease Products Offered
- 11.8.5 GlaxoSmithKline plc. Recent Development
- 11.9 Ionis Pharmaceuticals, Inc.
- 11.9.1 Ionis Pharmaceuticals, Inc. Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Ionis Pharmaceuticals, Inc. Lou Gehrigs Disease Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Ionis Pharmaceuticals, Inc. Lou Gehrigs Disease Products Offered
- 11.9.5 Ionis Pharmaceuticals, Inc. Recent Development
- 11.10 Mitsubishi Tanabe Pharma Corp.
- 11.10.1 Mitsubishi Tanabe Pharma Corp. Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Mitsubishi Tanabe Pharma Corp. Lou Gehrigs Disease Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Mitsubishi Tanabe Pharma Corp. Lou Gehrigs Disease Products Offered
- 11.10.5 Mitsubishi Tanabe Pharma Corp. Recent Development
- 11.11 Neuralstem Inc.
- 11.12 Neuraltus Pharmaceuticals Inc.
- 11.13 Newron Pharmaceuticals S.p.A.
- 11.14 Nutra Pharma Corp.
- 11.15 Pharnext SAS
- 11.16 Q-Therapeutics Inc.
12 Future Forecast
- 12.1 Lou Gehrigs Disease Market Forecast by Regions
- 12.1.1 Global Lou Gehrigs Disease Sales Forecast by Regions 2019-2025
- 12.1.2 Global Lou Gehrigs Disease Revenue Forecast by Regions 2019-2025
- 12.2 Lou Gehrigs Disease Market Forecast by Product
- 12.2.1 Global Lou Gehrigs Disease Sales Forecast by Product 2019-2025
- 12.2.2 Global Lou Gehrigs Disease Revenue Forecast by Product 2019-2025
- 12.3 Lou Gehrigs Disease Market Forecast by End User
- 12.4 North America Lou Gehrigs Disease Forecast
- 12.5 Europe Lou Gehrigs Disease Forecast
- 12.6 Asia Pacific Lou Gehrigs Disease Forecast
- 12.7 Central & South America Lou Gehrigs Disease Forecast
- 12.8 Middle East and Africa Lou Gehrigs Disease Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Lou Gehrigs Disease Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Lou Gehrigs Disease . Industry analysis & Market Report on Lou Gehrigs Disease is a syndicated market report, published as Global Lou Gehrigs Disease Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Lou Gehrigs Disease market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
